|
Characteristic
|
IMRT alone
|
CCRT
|
NACT + CCRT
|
CCRT + AC
|
P
|
|---|
|
Age(years)
| | | | |
0.099
|
|
Median
|
42
|
44
|
38
|
33
| |
|
Range
|
18-78
|
13-70
|
16-63
|
31-57
| |
|
Gender
| | | | |
0.598
|
|
Male
|
24
|
56
|
66
|
10
| |
|
Female
|
9
|
16
|
16
|
1
| |
|
T stage
| | | | |
0.097
|
|
T1-2
|
17
|
28
|
23
|
3
| |
|
T3-4
|
16
|
44
|
59
|
8
| |
|
N stage
| | | | |
0.087
|
|
N2
|
32
|
62
|
67
|
11
| |
|
N3
|
1
|
10
|
15
|
0
| |
|
Histology
| | | | |
0.740
|
|
WHO I
|
0
|
0
|
1
|
0
| |
|
WHO II
|
5
|
7
|
9
|
0
| |
|
WHO III
|
28
|
65
|
72
|
11
| |
- Abbreviation: IMRT alone: intensity-modulated radiotherapy alone; CCRT: concurrent chemoradiotherapy; NACT + CCRT: neoadjuvant chemotherapy and concurrent chemoradiotherapy; CCRT + AC: concurrent chemoradiotherapy and adjuvant chemotherapy.
